GlassScriptPhysician profile
Andrew C Vaughn
NPI 1972981439
$3,849.53
in general payments reported to CMS, 2019-2025
16 companies · $2,202 in 2025
The $2,202 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2021: $47.60 · 2022: $313 · 2023: $294 · 2024: $262 · 2025: $2,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539 · Travel and Lodging: $1,120 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.08 |
| Travel and Lodging | $1,119.73 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,411.87 | 2022-2025 | Scopis Ent, Xpress Loprofile, Omnicurve |
| Inspire Medical Systems, INC. | $825.29 | 2023-2025 | Inspire |
| Olympus Corporation of The Americas | $707.54 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $198.74 | 2022-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $133.03 | 2025 | Voquezna |
| Glaxosmithkline, LLC. | $123.03 | 2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Biotissue Holdings INC. | $78.15 | 2024 | |
| Medtronic, INC. | $74.19 | 2022-2025 | Pteye Parathyroid Detection System |
| Integra Lifesciences Corporation | $47.60 | 2021 | |
| Genzyme Corporation | $32.33 | 2024 | |
| Amgen INC. | $30.58 | 2025 | Tezspire |
| Smith+Nephew, INC. | $25.94 | 2025 | Halo |
| Olympus America INC. | $23.53 | 2019 | |
| Cochlear Americas | $20.53 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.19 | 2025 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Vaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.